全文获取类型
收费全文 | 3618篇 |
免费 | 216篇 |
国内免费 | 21篇 |
专业分类
耳鼻咽喉 | 22篇 |
儿科学 | 82篇 |
妇产科学 | 53篇 |
基础医学 | 423篇 |
口腔科学 | 54篇 |
临床医学 | 252篇 |
内科学 | 959篇 |
皮肤病学 | 67篇 |
神经病学 | 319篇 |
特种医学 | 163篇 |
外科学 | 706篇 |
综合类 | 10篇 |
预防医学 | 61篇 |
眼科学 | 30篇 |
药学 | 169篇 |
中国医学 | 5篇 |
肿瘤学 | 480篇 |
出版年
2024年 | 4篇 |
2023年 | 46篇 |
2022年 | 69篇 |
2021年 | 141篇 |
2020年 | 98篇 |
2019年 | 111篇 |
2018年 | 136篇 |
2017年 | 100篇 |
2016年 | 129篇 |
2015年 | 116篇 |
2014年 | 164篇 |
2013年 | 154篇 |
2012年 | 259篇 |
2011年 | 252篇 |
2010年 | 135篇 |
2009年 | 101篇 |
2008年 | 246篇 |
2007年 | 244篇 |
2006年 | 186篇 |
2005年 | 224篇 |
2004年 | 199篇 |
2003年 | 178篇 |
2002年 | 157篇 |
2001年 | 50篇 |
2000年 | 45篇 |
1999年 | 49篇 |
1998年 | 26篇 |
1997年 | 26篇 |
1996年 | 25篇 |
1995年 | 16篇 |
1994年 | 12篇 |
1993年 | 16篇 |
1992年 | 15篇 |
1991年 | 13篇 |
1990年 | 6篇 |
1989年 | 13篇 |
1988年 | 8篇 |
1987年 | 14篇 |
1986年 | 5篇 |
1985年 | 5篇 |
1984年 | 5篇 |
1976年 | 4篇 |
1975年 | 4篇 |
1974年 | 8篇 |
1972年 | 4篇 |
1971年 | 3篇 |
1970年 | 4篇 |
1969年 | 3篇 |
1967年 | 3篇 |
1966年 | 5篇 |
排序方式: 共有3855条查询结果,搜索用时 15 毫秒
71.
72.
Satoshi Kutsuna Yusuke Asai Kei Yamamoto Michinori Shirano Keiji Konishi Tomohiro Asaoka Masaya Yamato Yukiko Katsuragi Yudai Yamamoto Toshinori Sahara Aya Tamiya Fukumi Nakamura-Uchiyama Naoya Sakamoto Atsushi Kosaka Takuya Washino Ryota Hase Haruki Mito Takashi Kurita Norio Ohmagari 《Journal of infection and chemotherapy》2021,27(4):632-638
IntroductionThe epidemiology of infectious diseases in Japan remains undefined despite the increasing tourism. GeoSentinel, an epidemiological surveillance system for reporting imported infectious diseases, has only two participating facilities in Japan. Although the number of infectious diseases is reported by the National Institute of Infectious Diseases, there is no detailed clinical information about these cases. Therefore, we established J-RIDA (Japan Registry for Infectious Diseases from Abroad) to clarify the status of imported infectious diseases in Japan and provide detailed information.MethodsJ-RIDA was started as a registry of imported infectious diseases. Case registration began in October 2017. Between October 2017 and September 2019, 15 medical institutions participated in this clinical study. The registry collected information about the patient's age, sex, nationality, chief complaint, consultation date, date of onset, whether visit was made to a travel clinic before travel, blood test results (if samples were collected), travel history, and final diagnosis.ResultsOf the 3046 cases included in this study, 46.7% to Southeast Asia, 13.0% to Africa, 13.7% to East Asia, 11.5% to South Asia, 7.5% to Europe, 3.8% to Central and South America, 4.6% to North America, 3.9% to Oceania, and 2.8% to Central and west Asia. More than 85% of chief complaints were fever and general symptoms, gastrointestinal symptoms, respiratory symptoms, or dermatologic problems. The most common diseases were travelers’ diarrhea, animal bite, upper respiratory infection, influenza, and dengue fever.ConclusionsWe summarized two-year cases registered in Japan's imported infectious disease registry. These results will significantly contribute to the epidemiology in Japan. 相似文献
73.
74.
75.
76.
77.
Staging laparoscopy leads to rapid induction of chemotherapy for unresectable pancreatobiliary cancers 下载免费PDF全文
Daisuke Hashimoto Akira Chikamoto Kazuya Sakata Shigeki Nakagawa Hiromitsu Hayashi Masaki Ohmuraya Masahiko Hirota Naoya Yoshida Toru Beppu Hideo Baba 《Asian journal of endoscopic surgery》2015,8(1):59-62
Preoperatively evaluating the resectability of pancreatobiliary cancers is difficult. The aim of this study was to investigate the benefit of staging laparoscopy in unresectable pancreatobiliary cancers. Between 2010 and 2013, 25 patients with pancreatobiliary cancers underwent staging laparoscopy after conventional tumor staging; they were compared with 10 patients who had unresectable or metastatic tumors that were found during laparotomy. Staging laparoscopy did not show unresectable factors in 11 patients, and resections were performed in these patients. Unresectable factors were found in other 14 patients who underwent staging laparoscopy. In these patients, chemotherapy was started after median postoperative day 3 (range, 2–10 days). This period was significantly longer in patients who received unnecessary laparotomy; chemotherapy was started after median postoperative day 11 (range, 6–15 days). These results suggest that staging laparoscopy, while avoiding laparotomy with unsuccessful resection, can lead to rapid induction of chemotherapy for unresectable pancreatobiliary cancers. 相似文献
78.
Tatsuro Sass Ken-ichiro Kobayashi Masayuki Ot Takuya Washino Mayu Hikone Naoya Sakamoto Sentaro Iwabuchi Mizuto Otsuji Kenji Ohnishi 《中华创伤杂志(英文版)》2015,18(6):360-362
Most mediastinal abscesses result from infections after thoracotomy, esophageal perforation or penetrating chest trauma. This disease is rarely caused by closed blunt chest trauma. All previously reported such cases after closed blunt chest trauma presented with hematoma and sternal osteomyelitis resulting from sternal fracture. Here we report a 15-year-old sumo wrestler who presented with an anterior mediastinal abscess without any mediastinal fracture. The mediastinal abscess resulted from the hematogenous spread of Staphylococcus aureus to a hematoma that might have been caused by a closed blunt chest trauma incurred during sumo wrestling exercises. 相似文献
79.
Toshiya Muramatsu Ken Kozuma Reiko Tsukahara Yoshiaki Ito Naoya Fujita Satoru Suwa Shiho Koyama Masahiko Saitoh Haruo Kamiya Masato Nakamura 《Catheterization and cardiovascular interventions》2007,70(5):677-682
OBJECTIVES: To assess the myocardium-reperfusing effect of a distal protection device, GuardWire Plus (GuardWire Plus), in patients with acute myocardial infarction (AMI). BACKGROUND: Distal embolization may result in reduced myocardial perfusion, increasing the risk of non-Q-wave myocardial infarction and death. Distal protection devices may protect the microcirculation from embolic debris, improving short- and long-term clinical outcomes. METHODS: From February 2002 to July 2003, a total of 341 AMI patients at 22 institutions in Japan were enrolled in the present, multicenter, prospective, randomized trial. Patients experiencing AMI within 12 hr of symptom onset, who were considered treatable by stenting and who met the inclusion criteria, were eligible for randomization. Stenting with and without GuardWire Plus was conducted to examine whether the device provides faster and more complete ST-segment resolution, smaller infarct size, and improved myocardial blush score. RESULTS: The rates of slow flow and no-reflow immediately after PCI were 5.3 and 11.4% in the GuardWire Plus and control groups, respectively (P = 0.05). Blush score 3 acquisition rates immediately after PCI were 25.2 and 20.3% in the GuardWire Plus and control groups, respectively (P = 0.26), and the rates at 30 days after PCI were 42.9 and 30.4%, respectively (P = 0.035). CONCLUSIONS: A significant difference was found between the GuardWire Plus and control groups with respect to the total incidence of distal embolization, indicating that GuardWire Plus angiographically improved myocardial perfusion without demonstrating the preventive effect of myocardial damage. 相似文献